Key result
Initiating antihypertensive therapy based on a combination of blood pressure thresholds and quantitative cardiovascular risk assessment prevented more cardiovascular events and decreased the number needed to treat by 9 compared to a strategy based solely on a blood pressure threshold of 140/90 mmHg.
Why the study?
The health benefits and intervention efficiency of different strategies for initiating antihypertensive therapy for primary prevention of cardiovascular diseases in a community-based Chinese population needed evaluation.
Does initiating antihypertensive therapy based on cardiovascular risk assessment combined with SBP thresholds improve health benefits and intervention efficiency compared to purely SBP threshold-based strategies in Chinese adults?
Does initiating antihypertensive therapy based on cardiovascular risk assessment combined with SBP thresholds improve health benefits and intervention efficiency compared to purely SBP threshold-based strategies in Chinese adults?
Effect estimate: NNT decreased by 9
Initiating antihypertensive therapy based on a combination of cardiovascular risk assessment and SBP thresholds is more efficient than strategies based purely on SBP thresholds in a Chinese community population.
May improve prevention efficiency in Chinese adults; leaves open prospective validation before practice change.
OBJECTIVE: To evaluate the health benefits and intervention efficiency of different strategies of initiating antihypertensive therapy for the primary prevention of cardiovascular diseases in a community-based Chinese population from the Chinese electronic health records research in Yinzhou (CHERRY) study. METHODS: ). The high 10-year cardiovascular risk was defined as the predicted risk over 10% based on the 2019 World Health Organization cardiovascular disease risk charts. Different strategies were simulated by the Markov model for ten years (cycles), with parameters mainly from the CHERRY study or published literature. After ten cycles of simulation, the numbers of quality-adjusted life years (QALY), cardiovascular events and all-cause deaths were calculated to evaluate the health benefits of each strategy, and the numbers needed to treat (NNT) for each cardiovascular event or all-cause death could be prevented were calculated to assess the intervention efficiency. One-way sensitivity analysis on the uncertainty of incidence rates of cardiovascular disease and probabilistic sensitivity analysis on the uncertainty of hazard ratios of interventions were conducted. RESULTS: : 13-37) with better efficiency. The results were consistent in the sensitivity analyses. CONCLUSION: When initiating antihypertensive therapy in an economically developed area of China, the strategy combined with cardiovascular risk assessment is more efficient than those purely based on the SBP threshold. The cardiovascular risk assessment strategy with different SBP thresholds is suggested to balance health benefits and intervention efficiency in diverse populations.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2024) studied Primary prevention of cardiovascular diseases (n=213,795). Antihypertensive therapy initiation based on quantitative cardiovascular risk assessment vs. Initiation based solely on blood pressure thresholds (e.g., ≥140/90 mmHg or ≥130/80 mmHg) was evaluated on Number of prevented cardiovascular disease events and Number Needed to Treat (NNT) (NNT decreased by 9). Initiating antihypertensive therapy based on a combination of blood pressure thresholds and quantitative cardiovascular risk assessment prevented more cardiovascular events and decreased the number needed to treat by 9 compared to a strategy based solely on a blood pressure threshold of 140/90 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: